The expression of arsenic transporters, MRP1, MRP2 and ASNA1, correlates negatively with leukemia MDR cells’ ATO-sensitivity.
ATO enhances and inhibits the transporters’ expression in arsenic-resistant and -sensitive leukemia MDR cells, respectively.
The transporters’ expression and response to arsenic stress determine leukemia MDR cells’ ATO-sensitivity.